# Comparison of thoracoscopy-guided thoracic paravertebral block and patient-controlled intravenous analgesia for postoperative analgesia after uniportal thoracoscopic pulmonary wedge resection: a prospective randomized controlled trial

**Authors:** Jianhui Du, Luyao Wei, Jinxian He, Xia Xu, Lihong Hu

PMC · DOI: 10.3389/fmed.2025.1554515 · Frontiers in Medicine · 2025-05-15

## TL;DR

This study compares two pain management techniques after a lung surgery, finding that one method provides better pain relief and fewer side effects.

## Contribution

The study evaluates the effectiveness of a novel thoracic paravertebral block technique compared to standard intravenous analgesia.

## Key findings

- TG-TPB resulted in lower pain scores and reduced opioid use compared to PCIA.
- Patients receiving TG-TPB had fewer adverse reactions and better recovery quality.
- The benefits of TG-TPB were observed within the first 24 hours post-surgery.

## Abstract

Patients often experience persistent, intense pain following uniportal thoracoscopic pulmonary wedge resection (UTPWR). This pain is usually intervened with patient-controlled intravenous analgesia (PCIA) or thoracoscopic-guided thoracic paravertebral block (TG-TPB), a novel peripheral nerve block technique. Herein, we compared the analgesic effects of TG-TPB and PCIA post-UTPWR.

Sixty patients allocated into two groups: T and P. Group T patients were administered TG-TPB with 20 mL 0.375% ropivacaine at the fourth intercostal plane before sealing the chest, and connected to a PCIA pump containing 0.9% sodium chloride (NaCl). Group P patients received TG-TPB with 20 mL 0.9% NaCl and were connected to a PCIA pump containing sufentanil. The Visual Analogue Scale (VAS) scores were recorded at 2, 6, 12, 24, 36, and 48 h postoperatively. Data on sufentanil consumption, number of PCIA presses, number of rescue analgesia interventions, adverse reactions (ARs), and the 15-item Quality of Recovery Scale (QoR-15) scores were also recorded within 24 h postoperatively.

Compared to the P group, the T group showed lower VAS scores at 2, 6, 12, and 24 h postoperatively, as well as lower sufentanil consumption levels, number of PCIA presses, number of rescue analgesia interventions, and ARs incidences within 24 h postoperatively (all p < 0.05). Furthermore, the T group showed higher QoR-15 scores within 24 h postoperatively than the P group (90.5 ± 7.3 vs. 76.6 ± 6.2; p < 0.001).

Compared to PCIA, TG-TPB exerted a better analgesic effect post-UTPWR, with less opioid drug use, fewer ARs, and a significantly better recovery quality within 24 h postoperatively.

https://www.chictr.org.cn/, ChiCTR2000034726.

## Linked entities

- **Chemicals:** ropivacaine (PubChem CID 71273), sufentanil (PubChem CID 41693), sodium chloride (PubChem CID 5234)

## Full-text entities

- **Diseases:** pain (MESH:D010146)
- **Chemicals:** sufentanil (MESH:D017409), TG (MESH:D013866)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12119587/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12119587/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12119587/full.md

---
Source: https://tomesphere.com/paper/PMC12119587